The efficacy and safety of selective leukocytapheresis in the treatment of ulcerative colitis: a meta-analysis

@article{Zhu2011TheEA,
  title={The efficacy and safety of selective leukocytapheresis in the treatment of ulcerative colitis: a meta-analysis},
  author={Mingming Zhu and Xitao Xu and Fang Nie and Jinlu Tong and Shudong Xiao and Zhihua Ran},
  journal={International Journal of Colorectal Disease},
  year={2011},
  volume={26},
  pages={999-1007}
}
The use of selective leukocytapheresis for the treatment of ulcerative colitis (UC) has been evaluated in several open and controlled trials, with varying outcomes. A meta-analysis was performed to better assess the efficacy and safety of selective leukocytapheresis as supplemental therapy compared with conventional pharmacotherapy in patients with UC. All randomized trials comparing selective leukocytapheresis supplementation with conventional pharmacotherapy were included from electronic… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.

References

Publications referenced by this paper.
Showing 1-10 of 32 references

Intensive granulocyte and monocyte adsorption versus intravenous prednisolone in patients with severe ulcerative colitis: an unblinded randomised multi-centre controlled study.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver • 2008
View 6 Excerpts
Highly Influenced

Treatment of patients with acute ulcerative colitis: conventional corticosteroid therapy (MP) versus granulocytapheresis (GMA): a pilot study.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver • 2007